Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of DFN-11 in Medication Overuse Headache
NCT02583425Phase 2Terminated
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sumatriptan in medication overuse headache (MOH), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Number of Headache Hours. Started Sep 2015; status: terminated.
02
Drugs
sumatriptan
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on NCT02583425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583425.